WHO vaccine-preventable diseases: monitoring system. 2015 global summary

Last updated 2-Jul-2015 (Data received as of 26-June-2015)
Next overall update Mid July 2015
2014 data are provisional
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 1'3801 Infant (under 12 months) mortality rate: 762
GDP / capita (US$): 3'0121 Child (under 5 years) mortality rate: 1082

Population data in thousands3

  2014  2013  2012  2011  2010  2000  1990  1980 
Total population 20'805  20'316  19'840  19'390  18'977  16'131  12'116  8'266 
Births 757  745  731  715  698  614  503  400 
Surviving infants 703  690  675  659  642  555  450  353 
Pop. less than 5 years 3'301  3'196  3'088  2'997  2'935  2'637  2'107  1'599 
Pop. less than 15 years 8'567  8'397  8'227  8'070  7'935  6'791  5'392  3'757 
Female 15-49 years 4'944  4'807  4'675  4'548  4'427  3'660  2'560  1'703 

Number of reported case

(Click for retrospective incidence data for Côte d'Ivoire)
Diphtheria
Japanese encephalitis
Measles 50  48  137  628  441  5'729  17'799  7'633 
Mumps
Pertussis 3'052 
Polio* 36  28  47 
Rubella 54  98  298  43  31 
Rubella (CRS)
Tetanus (neonatal) 12  15  30  364 
Tetanus (total)** 12  15  384 
Yellow fever 21  10  49 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Côte d'Ivoire)
Vaccine year result method % card seen                                                
BCG 2013  91  CES   75  84  90  99  74  91  76 
DTP1 2013  89  CES   75  93  99*  75  95  83 
DTP3 2013  82  CES   75  87  99*  94  62  85  62 
HepB_BD         
HepB3 2013  82  CES   75  87  99*  94  62  85 
Hib3 2013  82  CES   75  87  99*  94  62  85 
JapEnc         
MCV          72  85  85  49  70  62 
MCV2         
PCV1          15 
PCV3         
Pol3 2013  78  CES   75  85  98  94  58  81  61  56 
Rota1         
Rota_last         
Rubella1         
TT2plus 2012  71  EPI   88  77  81  84  59  62  78 
PAB         
VAD1          75  99*  99* 
YFV 2013  69  CES   75  58  84  81  49  69  55 
  ° indicates that more than 1 survey occurred that year

  Next update: Mid July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Côte d'Ivoire)
BCG 84  93  74  91  80  62 
DTP1 93  93  75  95  85  77 
DTP3 88  82  62  85  65  54 
HepB3 88  82  62  85 
HepB_BD
Hib3 88  82  62  85 
MCV 74  74  49  70  68  56 
MCV2
PAB 82  82  82  82  76  36 
PCV3
Pol3 87  83  58  81  66  56 
Rota_last
YFV 76  73  49  69  60 

Number of districts in the country 82  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 44
From 80 to 89% 30
From 50 to 79% 26
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2014 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
HPV No From October 2015
IPV 14 weeks; Yes From June 2015
Measles 9 months; Yes
OPV birth; 6, 10, 14 weeks; Yes
Pneumo_conj 6, 10, 14 weeks; Yes
Rotavirus 6, 10, 14 weeks; Yes From October 2015
TT 1st contact pregnancy; +1, +6 months; +1, +1 year; Yes
VitaminA 6, 12, 18, 24, 30, 36 months; Yes
YF 9 months; Yes

Immunizaton indicators

Indicator Expected answer 2014  2013  2012  2011  2010  2009  2008 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2011-2015  2011-2015  2011-2015  2011 - 2015  2011-2015  2007-2011  2007-2011 
Nº of districts with microplans that include activities to raise immunization coverage number 82  82  82  102  83  83   

System performance

Total Nº districts in country number 82  82    102  83  83  72 
Nº districts with DTP3 coverage >=80% number 61  81  14  53  47  35 
% of districts with DTP3 coverage >=80% From 0 to 100% 74  99    14  64  57  49 
Nº districts with measles (MCV1) coverage >=95% number 19   
% of districts with MCV1 coverage >=95% From 0 to 100% 23   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  No  No  No     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  No  No  No  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 10  83    35  53  32  35 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes     

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.